TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36218395

Group type: EXPERIMENTAL
Intervention: Rhomboid intercostal and subserratus plane (RISS) block + intravenous patient‐controlled analgesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous patient‐controlled analgesia
Number of subjects: 40
Study: 34816917

Group type: EXPERIMENTAL
Intervention: Combined doxofylline and salbutamol treatment for 1 week
Number of subjects: 68

Group type: COMPARATOR
Intervention: Doxofylline treatment for 1 week
Number of subjects: 68
Study: 32241638

Group type: EXPERIMENTAL
Intervention: ledipasvir/sofosbuvir with ribavirin (RBV)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: sofosbuvir/RBV
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: paritaprevir/ombitasvir/RBV
Number of subjects: 120
Study: 36314766

Group type: EXPERIMENTAL
Intervention: Mobile healthcare apps
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no mobile app intervention)
Number of subjects: 0
Study: 33089427

Group type: EXPERIMENTAL
Intervention: Topping-off (T/O) cohort with posterior dynamic stabilising devices (PDSs)
Number of subjects: 571

Group type: COMPARATOR
Intervention: No topping-off (NoT/O) cohort
Number of subjects: 571
Study: 35022004

Group type: EXPERIMENTAL
Intervention: Intervention menu with nudging and boosting elements (comic character, fun attractive name, information on low calorie density)
Number of subjects: 607

Group type: COMPARATOR
Intervention: Control menu with standardized format including healthy target dish
Number of subjects: 607
Study: 32347591

Group type: EXPERIMENTAL
Intervention: High-frequency pulse (HFP) TLNS plus physical therapy (PT)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Low-frequency pulse (LFP) TLNS plus physical therapy (PT)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Pooled population (HFP + PT and LFP + PT)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Both groups (HFP + PT and LFP + PT)
Number of subjects: 122
Study: 34864768

Group type: EXPERIMENTAL
Intervention: Music Upper Limb Therapy-Integrated (MULT-I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Home Exercise Program (HEP)
Number of subjects: 30
Study: 33078636

Group type: EXPERIMENTAL
Intervention: Multi-Ingredient Performance Supplement (MIPS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study: 34247847

Group type: EXPERIMENTAL
Intervention: Lag screw fixation (two 1.5‐mm fully threaded bicortical screws using a lag technique)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nonlag screw fixation (two 1.5‐mm fully threaded bicortical nonlag screws)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (2 crossed 1.14‐mm K‐wires)
Number of subjects: 24
Study: 32727613

Group type: EXPERIMENTAL
Intervention: PrEP with hydroxychloroquine (400mg daily for 4 days, then 400mg weekly for 6 months)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo (identical appearance to hydroxychloroquine, same schedule)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: PrEP with hydroxychloroquine
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440

Group type: COMPARATOR
Intervention: Non-PrEP group (placebo)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Confirmed COVID-19 cases
Number of subjects: 440
Study: 35931991

Group type: EXPERIMENTAL
Intervention: i-HCH transitional care
Number of subjects: 0

Group type: COMPARATOR
Intervention: usual transitional care
Number of subjects: 0
Study: 35446066

Group type: EXPERIMENTAL
Intervention: Favorite music at 90, 120, and 150 bpm
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Unfamiliar, genre-matched music at 90, 120, and 150 bpm
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Favorite music
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Favorite music at slowest tempo
Number of subjects: 83
Study: 36435233

Group type: EXPERIMENTAL
Intervention: Adenosine and dipyridamole
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1000

Group type: COMPARATOR
Intervention: No treatment with antithrombotic drugs
Number of subjects: 1000
Study: 33466183

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg, maximum dose 24 mg)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 105
Study: 32580752

Group type: EXPERIMENTAL
Intervention: Shenhuang granule treatment twice a day for 14 days
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 160
Study: 35225115

Group type: EXPERIMENTAL
Intervention: Neutropenic diet (n=21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard Indian diet (n=21)
Number of subjects: 42
Study: 33221589

Group type: EXPERIMENTAL
Intervention: Herbal medicine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 29
Study: 33865841

Group type: EXPERIMENTAL
Intervention: 16.25 g fiber diet
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 32.5 g fiber diet
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 13C-mannitol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: lactulose
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: rhamnose
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: sucralose
Number of subjects: 60
Study: 32119821

Group type: EXPERIMENTAL
Intervention: Shortened mosaic HIV‐1 vaccine schedules
Number of subjects: 0
Study: 35369762

Group type: COMPARATOR
Intervention: Conventional physiotherapy (CPT) treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: CPT with knee traction from full extension
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CPT with knee traction from 90° flexion
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CPT with knee traction from 20° flexion
Number of subjects: 120
Study: 33443234

Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH with airflow obstruction (FEV1/FVC<0.70)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH with airflow obstruction (based on FEV1/FVC<lower limit of normal)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH with airflow obstruction (FEV1)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH with airflow obstruction (FEV1/FVC)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Global methylation in PLWH with airflow obstruction
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profiles in PLWH
Number of subjects: 161
Study: 34011386

Group type: EXPERIMENTAL
Intervention: Long BPL RYGB
Number of subjects: 800

Group type: COMPARATOR
Intervention: Short BPL RYGB
Number of subjects: 800
Study: 36027848

Group type: COMPARATOR
Intervention: Resistance exercise (REx)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation combined with resistance exercise (NMES+REx)
Number of subjects: 43
Study: 33238012

Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted THA
Number of subjects: 170

Group type: COMPARATOR
Intervention: Manual THA
Number of subjects: 170
Study: 32012217

Group type: EXPERIMENTAL
Intervention: Cordotomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (sham procedure)
Number of subjects: 0
Study: 35840851

Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Formula (BSHXF) combined with lumbar traction
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo combined with lumbar traction
Number of subjects: 70
Study: 32641343

Group type: EXPERIMENTAL
Intervention: Intravenous high-dose vitamin C (HIVC) diluted in sterile water for 7 days
Number of subjects: 308

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study: 35978943

Group type: EXPERIMENTAL
Intervention: Music-with-movement intervention for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Music-with-movement intervention for caregivers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focus group interviews
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuation of intervention by families
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 33320197

Group type: EXPERIMENTAL
Intervention: Identified and treated intrauterine adhesions (IUAs)
Number of subjects: 152

Group type: COMPARATOR
Intervention: No intrauterine adhesions (IUAs)
Number of subjects: 152
Study: 32619609

Group type: COMPARATOR
Intervention: sprifermin 100 μg q6mo
Number of subjects: 549

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 549
Study: 34739632

Group type: EXPERIMENTAL
Intervention: Feedback condition (diagnosed a case, rated confidence, received feedback)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control condition (diagnosed a case, rated confidence, no feedback)
Number of subjects: 69
Study: 33821515

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: CPT with written account (CPT+A)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Written account only (WA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (non-substance-involved SA)
Number of subjects: 58
Study: 32240835

Group type: EXPERIMENTAL
Intervention: Smartphone application (APP) for reinforced education starting 3 days before colonoscopy
Number of subjects: 500
Study: 33019480

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy combined with multiple drilling and intramedullary drug injection (group EMI)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (group E)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Multiple drilling combined with intramedullary drug injection (group MI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Multiple drilling (positive control group; group M)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 34987480

Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Methimazole
Number of subjects: 36
Study: 32127151

Group type: EXPERIMENTAL
Intervention: Acupuncture (AG; n = 36)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (CG; n = 36)
Number of subjects: 72
Study: 36040201

Group type: EXPERIMENTAL
Intervention: Xiaoketongbi Formula (XF)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 68
Study: 32202337

Group type: EXPERIMENTAL
Intervention: First responder's care package training through workshops
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 150
Study: 35369712

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 128

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 128
Study: 34520831

Group type: EXPERIMENTAL
Intervention: PMCb (paclitaxel plus Myocet®-nonpegylated liposomal doxorubicin plus carboplatin)
Number of subjects: 133

Group type: COMPARATOR
Intervention: PM (paclitaxel plus Myocet®-nonpegylated liposomal doxorubicin)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: PMCb
Number of subjects: 133

Group type: COMPARATOR
Intervention: PM
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Carboplatin addition
Number of subjects: 133
Study: 36326639

Group type: EXPERIMENTAL
Intervention: Number lines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Icon arrays
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risk ladders
Number of subjects: 0

Group type: COMPARATOR
Intervention: No visual display
Number of subjects: 0
Study: 35013371

Group type: EXPERIMENTAL
Intervention: 3D printing-assisted percutaneous nephrolithotomy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional B-ultrasound-guided puncture method
Number of subjects: 90
Study: 34387225

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 84
Study: 32644833

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-dose ER-MPH (0.21 mg/kg equivalent of IR-MPH)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Medium-dose ER-MPH (0.35 mg/kg equivalent of IR-MPH)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-dose ER-MPH (0.48 mg/kg equivalent of IR-MPH)
Number of subjects: 24
Study: 33015164

Group type: EXPERIMENTAL
Intervention: Music intervention for 1 month
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard care with antipsychotic medication
Number of subjects: 45
Study: 32858606

Group type: EXPERIMENTAL
Intervention: Type D personality present in 225 patients (21%)
Number of subjects: 1055

Group type: COMPARATOR
Intervention: No Type D personality
Number of subjects: 1055
Study: 32320845

Group type: EXPERIMENTAL
Intervention: Tablet-assisted intervention (SPARK) consisting of interactive games and activities to improve provider fidelity and child engagement in evidence-based psychotherapies.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified; details on control intervention are not available.
Number of subjects: 0
Study: 33638105

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral subcostal TAPB
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control
Number of subjects: 112
Study: 34526073

Group type: EXPERIMENTAL
Intervention: Total or partial tonsillar resection (Tonsillectomy (TE) or Tonsillotomy (TT))
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Total tonsillar resection (Tonsillectomy (TE))
Number of subjects: 285

Group type: COMPARATOR
Intervention: Watchful waiting (WW)
Number of subjects: 285
Study: 35804322

Group type: EXPERIMENTAL
Intervention: WWACP (e-health enabled health promotion intervention)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 351
Study: 33175618

Group type: EXPERIMENTAL
Intervention: Two-layer bandage
Number of subjects: 186

Group type: COMPARATOR
Intervention: Four-layer bandage
Number of subjects: 186
Study: 36109757

Group type: EXPERIMENTAL
Intervention: Behavior science-based intervention program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual practices (Control)
Number of subjects: 30
Study: 32995974

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Pseudoprogression (detected by iRECIST)
Number of subjects: 221
Study: 32521927

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization (TACE)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study: 34048504

Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac (5.12x10^4) administered via three direct venous inoculations (DVIs) seven days apart
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PfSPZ-CVac (1.024x10^5) administered via three direct venous inoculations (DVIs) five days apart
Number of subjects: 15

Group type: COMPARATOR
Intervention: PfSPZ-CVac (5.12x10^4) administered via three injections five days apart (previous study)
Number of subjects: 15
Study: 35358769

Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 60
Study: 33811250

Group type: EXPERIMENTAL
Intervention: Peg-interferon-α (peg-IFN-α) add-on treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peg-interferon-α (peg-IFN-α) switch treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peg-interferon-α (peg-IFN-α) therapy (both add-on and switch)
Number of subjects: 0
Study: 34007066

Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy (LiST)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 102
Study: 33593287

Group type: EXPERIMENTAL
Intervention: Mobile e‐learning, mentor‐led online social support networking, and monthly face‐to‐face mentoring support group meetings
Number of subjects: 140

Group type: COMPARATOR
Intervention: 8‐h conventional lectures
Number of subjects: 140
Study: 32723294

Group type: EXPERIMENTAL
Intervention: HDF group (once and twice weekly HDF)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Twice HDF subgroup
Number of subjects: 34

Group type: COMPARATOR
Intervention: Once HDF subgroup
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: OL-HDF (once a week)
Number of subjects: 34
Study: 35123450

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Schema Therapy (ST)
Number of subjects: 200
Study: 34826668

Group type: EXPERIMENTAL
Intervention: Dienogest (Visanne) 2 mg/day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Combined oral contraceptive (Yasmin, 0.03 mg ethinyl estradiol and 3 mg drospirenone)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dienogest and COC
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dienogest
Number of subjects: 70
Study: 33960309

Group type: EXPERIMENTAL
Intervention: Spironolactone (1:1 placebo-controlled treatment)
Number of subjects: 101
Study: 32672593

Group type: EXPERIMENTAL
Intervention: iStent Inject trabecular bypass stent (TBS) plus cataract surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cataract surgery alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TBS plus cataract surgery
Number of subjects: 0
Study: 35347557

Group type: EXPERIMENTAL
Intervention: Predilution hemodiafiltration (HDF)
Number of subjects: 38

Group type: COMPARATOR
Intervention: High-flux hemodialysis (HD)
Number of subjects: 38
Study: 32942939

Group type: EXPERIMENTAL
Intervention: Midline‐traction with restricted mouth opening (MR)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Bilateral thrust with opening permitted (BP)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both OAs
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Overall (both OAs)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Comparison of MR and BP OAs
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Baseline overjet measures >2.9 mm
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Mean and minimum SaO(2)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Severe OSA individuals
Number of subjects: 56
Study: 32394089

Group type: EXPERIMENTAL
Intervention: Patient-anatomy-specific rehearsal on a high-fidelity simulator prior to real angiography
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Structured simulation curriculum for angiographer novices
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no simulation)
Number of subjects: 40
Study: 34511181

Group type: EXPERIMENTAL
Intervention: Pharmacological treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychoeducational/behavioral treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neuromodulation treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized controlled trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Large case series
Number of subjects: 0
Study: 33239406

Group type: EXPERIMENTAL
Intervention: Singing for lung health (SLH)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 32995976

Group type: EXPERIMENTAL
Intervention: 1100F‐TMP‐MI Paste Plus
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: COMPARATOR
Intervention: 1100 ppm F (1100F)
Number of subjects: 72

Group type: COMPARATOR
Intervention: MI Paste Plus®
Number of subjects: 72

Group type: COMPARATOR
Intervention: 1100F + MI Paste Plus® (1100F‐MI Paste Plus)
Number of subjects: 72

Group type: COMPARATOR
Intervention: 1100F + 3 % TMP (1100F‐TMP)
Number of subjects: 72
Study: 32961242

Group type: EXPERIMENTAL
Intervention: Computational determination of wheal area using a Python algorithm and smartphone photographs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Temperature monitoring using an infrared temperature sensor
Number of subjects: 20
Study: 35354481

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Family-Supported Prolonged Exposure (PE with family involvement)
Number of subjects: 156
Study: 32942914

Group type: EXPERIMENTAL
Intervention: Daily mobile phone instructional text messages with standard care
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 79
Study: 32564438

Group type: EXPERIMENTAL
Intervention: Resveratrol (75 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36405604

Group type: EXPERIMENTAL
Intervention: Multiparameter EEG-guided sedation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (standard sedation protocol)
Number of subjects: 50
Study: 32578029

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy-based care (RTBC)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130
Study: 36244623

Group type: EXPERIMENTAL
Intervention: Early laser group (16+0/7 to 16+6/7 weeks' gestation)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Standard laser group (≥17 weeks' gestation)
Number of subjects: 343
Study: 33486869

Group type: EXPERIMENTAL
Intervention: High-phosphorus diet (HPD): 2300 mg/d
Number of subjects: 6
Study: 32044831

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 100
Study: 36200646

Group type: EXPERIMENTAL
Intervention: High-dose dual-impregnated antibiotic-loaded cement (DIAC) including gentamicin and clindamycin
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Low-dose single-impregnated gentamicin antibiotic-loaded cement (SIAC)
Number of subjects: 7000
Study: 33795330

Group type: EXPERIMENTAL
Intervention: Tofacitinib (TOFA) 5mg twice daily
Number of subjects: 87
Study: 34519018

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intranasal placebo
Number of subjects: 20
Study: 34588250

Group type: EXPERIMENTAL
Intervention: ICU-specific Virtual Reality for Family members/relatives (ICU-VR-F)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: ICU-VR-F
Number of subjects: 160
Study: 33905281

Group type: EXPERIMENTAL
Intervention: Exposure-Focused Cognitive Behavioral Therapy (EF-CBT)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Relaxation Mentorship Training (RMT)
Number of subjects: 102